FL- 101 Study in Non-Metastatic MIBC
NCT05395260
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Sponsor Decision
Conditions
Muscle Invasive Bladder Carcinoma
Interventions
DRUG:
FL-101
Sponsor
Flame Biosciences